110 related articles for article (PubMed ID: 19004847)
1. Role of matrix metalloproteinases in viral-associated glomerulonephritis.
Wörnle M; Roeder M; Sauter M; Ribeiro A
Nephrol Dial Transplant; 2009 Apr; 24(4):1113-21. PubMed ID: 19004847
[TBL] [Abstract][Full Text] [Related]
2. Effect of dsRNA on mesangial cell synthesis of plasminogen activator inhibitor type 1 and tissue plasminogen activator.
Wörnle M; Roeder M; Sauter M; Merkle M; Ribeiro A
Nephron Exp Nephrol; 2009; 113(2):e57-65. PubMed ID: 19590242
[TBL] [Abstract][Full Text] [Related]
3. Effect of tissue inhibitors of metalloproteinases and matrix metalloproteinases on capsular formation around smooth and textured silicone gel implants.
Ulrich D; Ulrich F; Pallua N; Eisenmann-Klein M
Aesthetic Plast Surg; 2009 Jul; 33(4):555-62. PubMed ID: 19330370
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease.
De S; Fenton JE; Jones AS
J Laryngol Otol; 2005 Jun; 119(6):436-42. PubMed ID: 15992468
[TBL] [Abstract][Full Text] [Related]
5. Role of viral induced vascular endothelial growth factor (VEGF) production in pleural effusion and malignant mesothelioma.
Wörnle M; Sauter M; Kastenmüller K; Ribeiro A; Roeder M; Mussack T; Ladurner R; Sitter T
Cell Biol Int; 2009 Feb; 33(2):180-6. PubMed ID: 18996210
[TBL] [Abstract][Full Text] [Related]
6. Human matrix metalloproteinases: characteristics and pathologic role in altering mesangial homeostasis.
Keeling J; Herrera GA
Microsc Res Tech; 2008 May; 71(5):371-9. PubMed ID: 18300288
[TBL] [Abstract][Full Text] [Related]
7. Role of matrix metalloproteinases in intestinal inflammation.
Medina C; Radomski MW
J Pharmacol Exp Ther; 2006 Sep; 318(3):933-8. PubMed ID: 16644899
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
Ito I; Fixman ED; Asai K; Yoshida M; Gounni AS; Martin JG; Hamid Q
Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858
[TBL] [Abstract][Full Text] [Related]
9. Analysis of alpha2-adrenergic receptors and effect of brimonidine on matrix metalloproteinases and their inhibitors in human ciliary body.
Ooi YH; Oh DJ; Rhee DJ
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4237-43. PubMed ID: 19324857
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
11. Role of matrix metalloproteinases in development of diabetic nephropathy.
Khasigov PZ; Ktzoeva SA; Gatagonova TM; Tareeva IE; Grachev SV; Berezov TT
Biochemistry (Mosc); 2000 May; 65(5):519-24. PubMed ID: 10851028
[TBL] [Abstract][Full Text] [Related]
12. A role for matrix metalloproteinases in granulocyte infiltration and testicular remodelation in a seasonal breeding teleost.
Chaves-Pozo E; Castillo-Briceño P; García-Alcázar A; Meseguer J; Mulero V; García-Ayala A
Mol Immunol; 2008 May; 45(10):2820-30. PubMed ID: 18342940
[TBL] [Abstract][Full Text] [Related]
13. [Current aspects in the pathogenesis and therapy of glomerulonephritis: significance of glomerular metalloproteinases].
Marti HP; Lovett DH
Schweiz Med Wochenschr; 1992 Nov; 122(45):1701-7. PubMed ID: 1439688
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical study of the role of matrix metalloproteinases and their tissue inhibitors in chronic mitral valvular disease (valvular endocardiosis) in dogs.
Aupperle H; Thielebein J; Kiefer B; März I; Dinges G; Schoon HA
Vet J; 2009 Apr; 180(1):88-94. PubMed ID: 18295518
[TBL] [Abstract][Full Text] [Related]
15. New strategy to treat glomerular inflammation by inhibition of mesangial cell matrix metalloproteinases.
Marti HP
Schweiz Med Wochenschr; 2000 May; 130(21):784-8. PubMed ID: 10904987
[TBL] [Abstract][Full Text] [Related]
16. Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases.
Gentner B; Wein A; Croner RS; Zeittraeger I; Wirtz RM; Roedel F; Dimmler A; Dorlaque L; Hohenberger W; Hahn EG; Brueckl WM
Anticancer Res; 2009 Jan; 29(1):67-74. PubMed ID: 19331134
[TBL] [Abstract][Full Text] [Related]
17. Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis.
Lovett DH; Johnson RJ; Marti HP; Martin J; Davies M; Couser WG
Am J Pathol; 1992 Jul; 141(1):85-98. PubMed ID: 1321565
[TBL] [Abstract][Full Text] [Related]
18. The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers.
Jeffery N; McLean MH; El-Omar EM; Murray GI
Histopathology; 2009 Jun; 54(7):820-8. PubMed ID: 19635101
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.
Di Sabatino A; Jackson CL; Pickard KM; Buckley M; Rovedatti L; Leakey NA; Picariello L; Cazzola P; Monteleone G; Tonelli F; Corazza GR; MacDonald TT; Pender SL
Gut; 2009 Jun; 58(6):777-89. PubMed ID: 19201776
[TBL] [Abstract][Full Text] [Related]
20. Expression of genes encoding matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in normal and diseased canine mitral valves.
Aupperle H; Thielebein J; Kiefer B; März I; Dinges G; Schoon HA; Schubert A
J Comp Pathol; 2009 May; 140(4):271-7. PubMed ID: 19285315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
